Procaps Group SA (PROC)

Name: Procaps Group SA (PROC) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Procaps Group SA (PROC)

Stock Card

$1.10

$0.00 (0.00%)

As on 11-Aug-2025 09:30EDT

Market cap

$114 Mln

Revenue (TTM)

$414 Mln

P/E Ratio

1.5

P/B Ratio

64.3

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Procaps Group SA (PROC) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.10 High: 1.10

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$40 Mln
ROE

0.4 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

22.7
Debt to Equity

5.6
Book Value

$--
EPS

$0.5
Face value

--
Shares outstanding

112,824,000

5 Years Aggregate

CFO

$253.60 Mln

EBITDA

$185.94 Mln

Net Profit

$-33.58 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Procaps Group SA (PROC)	-53.0	-21.4	-24.1	-45.0	-48.8	-35.7	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8

As on 11-Aug-2025 | *As on 28-Aug-2026

Company	2023	2022	2021	2020
Procaps Group SA (PROC)	-22.5	-46.2	-6.3	5.6
BSE Sensex	18.7	4.4	22.0	15.8
BSE Sensex	18.7	4.4	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Procaps Group SA (PROC)

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin... care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg. Read more

Founder & Executive Chairman

Mr. Ruben Minski
Founder & Executive Chairman

Mr. Ruben Minski
Headquarters

Luxembourg
Website

https://www.procapsgroup.com

FAQs for Procaps Group SA (PROC)

What is the current share price of Procaps Group SA (PROC) Today?

The share price of Procaps Group SA (PROC) is $1.10 (NASDAQ) as of 11-Aug-2025 09:30 EDT. Procaps Group SA (PROC) has given a return of -48.8% in the last 3 years.

What is the current PB & PE ratio of Procaps Group SA (PROC)?

The P/E ratio of Procaps Group SA (PROC) is 1.53 times as on 11-Aug-2025.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	12.48	-564.11
2021	-9.49	-25.59
2020	-112.32	-4.59
2019	-65.32	-4.55
2022	12.48	-564.11

What is the 52 Week High and Low of Procaps Group SA (PROC)?

The 52-week high and low of Procaps Group SA (PROC) are Rs -- and Rs -- as of 30-Aug-2026.

What is the market cap of Procaps Group SA (PROC)?

Procaps Group SA (PROC) has a market capitalisation of $ 114 Mln as on 11-Aug-2025. As per SEBI classification, it is a company.

Should I invest in Procaps Group SA (PROC)?

Before investing in Procaps Group SA (PROC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.